Korea University Medical Center-JNP Medi, Business Agreement for Clinical Digitalization

Jung Kwon-ho, CEO of J&P Medi (left), and Ham Byung-joo, Director of Medical Research at Korea University, are taking a commemorative photo after signing the agreement on the 13th.

[Asia Economy Reporter Kim Young-won] Korea University Medical Center and medical data platform company JNP Medi are establishing a clinical trial collaboration system.

Korea University Medical Center announced on the 15th that the two organizations agreed to build a cooperative relationship through a business agreement ceremony held on the 13th at Korea University Mediscience Park. The event was attended by Ham Byung-joo, Director of Medical Research at Korea University, key officials from Korea University Medical Center, and JNP Medi representatives including CEO Jung Kwon-ho.

This agreement aims to strengthen the cooperation system for enhancing the quality of clinical trial data and leading the clinical trial paradigm through the digitalization of clinical trials between Korea University Medical Center and JNP Medi.

Korea University Medical Center explained that it is promoting innovative development in clinical research by establishing a stable medical big data ecosystem through the complete transition of its medical information system to the cloud, the first among domestic tertiary hospitals. JNP Medi recently unveiled 'Maven Docs,' a clinical trial document creation and management solution.

Ham Byung-joo, Director of Medical Research, said, "Through this business agreement, we expect to establish comprehensive systems for conducting highly reliable clinical trials and to strengthen global clinical trial competitiveness."

CEO Jung Kwon-ho stated, "We look forward to various collaborations with Korea University Medical Center, which has excellent research capabilities," adding, "We will continuously develop and advance our software to overcome the limitations of existing clinical trials and constantly attempt new methods of clinical trials."

This content was produced with the assistance of AI translation services.